UK Venture Plans ‘Smart’ Randomized Trials To Speed Access To New Drugs
Sanofi Is First To Partner With Protas
Executive Summary
A newly launched UK venture is planning to use smart randomized clinical trial design in collaboration with industry, patient, academic and clinical partners to develop better treatments for a range of life-threatening diseases.
You may also be interested in...
The EU’s New Clinical Trial System Is Just Two Weeks Away: Are You Ready?
When the new Clinical Trial Information System goes live at the end of January, it will usher in many practical and operational considerations that sponsors need to be aware of.
EU Falsified Medicines Directive ‘Not Working’ In Northern Ireland
Industry representatives told a House of Lords committee about continuing Brexit-related problems such as the extra work involved in checking compliance with the EU Falsified Medicines Directive and the drawbacks of a proposed “dual regulatory regime.”
UK Regulator Says April Fee Rise Will Support 'Innovative & Efficient' Service
The Medicines and Healthcare products Regulatory Agency says that the fee increases to be introduced on 1 April, along with 18 new fees, are necessary for its long-term financial sustainability and its ability to provide a “responsive, innovative and efficient regulatory service.”